Continuing our Life-Long Commitment to Rare Disease Patients Around the World
As our global community continues to navigate the impact of COVID-19, CENTOGENE remains fully open and operational, underlining our continued commitment to patients globally.
ORDER ON CENTOPORTAL®

Back

Daily COVID-19 statistics from Frankfurt Airport* on 26.09.2020

Number of patients tested:

5,535

Negative results:

5,490

Positive results:

39

0.70%

Reports delivered within 24hrs:

90.63%

Reports delivered within 12hrs:

28.13%

*as one example of our support towards opening up the economies

Img Alt Text

Transforming Global Genetic Data into Medical Decisions

We are a global leader in rare disease diagnosis and research by transforming real-world clinical and genetic data into actionable information for patients, physicians, and pharmaceutical companies

Coronavirus Testing With CENTOGENE

Coronavirus Testing With CENTOGENE

Enabling you to get back to normal with our range of SARS-CoV-2 testing solutions for individuals and businesses

Read More

Improved Travel With Coronavirus Testing

Improved Travel With Coronavirus Testing

Reduce the risk of facing restrictions and quarantine measures at your destination with SARS-CoV-2 pre-flight testing at Frankfurt Airport

Read More

Improved Travel With Coronavirus Testing

The Latest Insights Into COVID-19

Keeping you up to date with the most recent news and scientific developments amid the Coronavirus pandemic

Read More

International Gaucher Day 2020

International Gaucher Day 2020

We want to shine a spotlight on the incredible people in the Gaucher community. Join the art competition and tell your story here!

Read More

Our goal: providing precise medical diagnosis of inherited diseases at the earliest possible moment; transforming medical expertise and analytical information into actionable results for physicians, patients, and pharmaceutical partners.

Our commitment: life-long support for our patients and partners - driven by the continuous improvement of our diagnostic quality and therapeutic options for individual patients.

Centogene’s latest Scientific Publications

Genetics and Pathophysiology of Premature Aging

Progeria, the phenomenon of premature aging, is an ultra-rare genetic condition. A recent…

One Gene – Two Mutational Mechanisms

For a few genes, mono-allelic gain-of-function mutations as well as bi-allelic…

A Variant-Specific Mutational Effect

A given genetic disorder is usually associated with numerous distinct mutations in the…

Underlining the Diagnostic Superiority of Genome Sequencing

Technological options for genetic diagnostics have evolved rapidly, with genome sequencing…

Mechanistic Insights Into Cancer Predisposition

Genetic predisposition to cancer is tightly linked to an increased rate of somatic…

Understanding Parkinson’s Disease on a Global Scale

Current insights into Parkinson’s disease (PD) are largely based on studies in Europe and…

Large Patient Cohort Enables Insights into a Rare Disease

Farber disease (FD) is a severe disorder for which rarity has hampered a comprehensive…

Unlocking the Genetics of Seizures

Seizures are frequently rooted in a genetic factor, but many of the corresponding…

A Novel Disorder of Nerve Cell Communication

Proper development and function of nerve cells relies on communication by so-called…

Epidemiology of a Rare Protein Aggregation Disorder

Some genetic disorders are caused by an accumulation of the mutated protein, with…

Customer Feedback

Give feedback

Newsletter subscription

CAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN, September 28, 2020 (Globe Newswire)

  • Company awarded ISO 27001 Accreditation for its Information Security...
Read more

CAMBRIDGE, Mass., ROSTOCK und BERLIN, Deutschland, 28. September, 2020

  • Unternehmen erhält ISO 27001-Akkreditierung für sein Information Security Management...
Read more

CAMBRIDGE, Mass., and ROSTOCK & BERLIN, Germany, September 23, 2020 (Globe Newswire) — Centogene N.V. (Nasdaq: CNTG) (“CENTOGENE” or the “Company”), a...

Read more

CAMBRIDGE, Mass. and ROSTOCK & BERLIN, Germany, September 23, 2020

  • CENTOGENE expands its SARS-CoV-2 testing solution to Düsseldorf Airport after successfully...
Read more

CAMBRIDGE, Mass., USA und ROSTOCK & BERLIN, Deutschland, 23. September 2020:

  • Nach erfolgreicher Inbetriebnahme von COVID-19-Testzentren an den Flughäfen...
Read more

CAMBRIDGE, Mass., and ROSTOCK & BERLIN, Germany, September 16, 2020 (Globe Newswire) – Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on...

Read more

CAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN, September 10, 2020

  • CENTOGENE has opened an expanded sampling area, next to the existing Walk-In COVID-19...
Read more

CAMBRIDGE, Mass., USA und ROSTOCK & BERLIN, Deutschland, 10. September 2020:

  • CENTOGENE eröffnet einen erweiterten Bereich zur Probenentnahme direkt neben dem...
Read more

CAMBRIDGE, Mass. and ROSTOCK and BERLIN, Germany, September 03, 2020 (Globe Newswire)

  • Publication demonstrates genome sequencing as the optimal standard for...
Read more